Introduction
PursueCare, a leader in virtual addiction treatment, has relaunched RESET and RESET-O, two FDA-cleared prescription digital therapeutics (PDTs), designed to help individuals struggling with substance use disorder (SUD) and opioid use disorder (OUD). Originally…
PursueCare, a company that provides personalized virtual addiction treatment, announced the re-release of FDA-cleared RESET and RESET-O, prescription digital therapeutics for substance use disorder and opioid use disorder.RESET and RESET-O were initially developed and…
Continue Reading
ORLANDO–Pawan Kohli of Redesign Health spoke at HIMSS24 Venture Connect on experiencing failure and the lessons startups can learn to ensure the company’s ability to thrive in an ever changing digital health market. Global digital…
Continue Reading
Welcome to our enlightening conversation with Gil Bashe, Chair of Global Health and Purpose at Finn Partners, a visionary leader at the intersection of healthcare and technology.In this engaging interview, we delve deep into…
Continue Reading
Top News
A Stat review says that digital therapeutics is stagnating in the US, as evidenced by vendor bankruptcies and lack of Medicare coverage for their products.
The authors note that Pear Therapeutics shut down…
The Fundraising and Acquisition of Digital Therapeutics for SUD Strengthens PursueCare’s Ability to Provide Care for Individuals with Addiction
PursueCare, a digital addiction treatment provider, today announced the completion of a Series B fundraising round…
The Access to Prescription Digital Therapeutics Act, initially introduced in the U.S. Senate in 2022 and reintroduced in March of this year, aims to amend the Social Security Act to provide Medicare and Medicaid…
Continue Reading
One of the fastest-growing frontiers of healthcare is Digital Therapeutics (DTx), which utilizes clinically tested software to prevent, treat, and manage a growing range of medical conditions. During Covid-19, governing agencies loosened regulatory requirements…
Continue Reading
On this episode of HTD, Jess and I check out Akili Interactive: at least it's still worth more than Pear Therapeutics. And by the way, what do we think will happen between Amazon and…
Continue Reading
Tech-enabled sleep health company Nox Health was the highest bidder of Pear Therapeutics’ Somryst assets at an auction last month that followed the prescription digital therapeutic company’s bankruptcy in April.Nox bid $3.9 million for…
Continue Reading
